• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ACELL, INC. GENTRIX SURGICAL MATRIX THIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ACELL, INC. GENTRIX SURGICAL MATRIX THIN Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Failure to Anastomose (1028)
Event Type  Injury  
Manufacturer Narrative
This mdr is being submitted due to the reported anastomotic leak after initial placement of the acell device.The acell device was explanted; however it is not available for evaluation.A review of the manufacturing records is not possible as the acell device, lot and serial number was not provided by the surgeon.Nevertheless, all acell devices are manufactured and distributed sterile in compliance with fda, state, local laws and regulations, and acell's operating procedures.We are submitting this report now, however, the investigation is ongoing and more information will be provided upon completion of the investigation.
 
Event Description
On (b)(6) 2019, acell, inc.Was notified by a physician that their patient developed an anastomotic leak and became septic, four (4) days after performing an anastamosis repair wrapped with an acell gentrix device.The surgeon was unable to provide the date of the surgery and the acell device used.We are submitting this report now, however, the investigation is ongoing and more information will be provided upon completion of the investigation.
 
Event Description
This is a follow-up report for additional and corrected information that was received subsequent to the initial filing.On (b)(6) 2019, acell, inc.Was notified by a physician that their patient developed an anastomotic leak and became septic, four (4) to five (5) days after perfoming an anastamosis repair wrapped with an acell gentrix device in 2014.The physician was unable to provide the date of the surgery and device lot and serial number.The physician stated he does not attribute the implanted acell device to the anastomotic leak.The physician repaired the leak, however, the patient developed a bowel obstruction six (6) to seven (7) months later.
 
Manufacturer Narrative
This is a follow-up report for additional information that was received subsequent to the initial filing.The physician was unable to provide further information regarding the issue in subsequent follow-up conversations.The initial mdr was submitted due to the reported anastomotic leak after initial placement of the acell device.The acell device was explanted; however it is not available for evaluation.A review of the manufacturing records is not possible as the acell device, lot and serial number was not provided by the surgeon.Nevertheless, all acell devices are manufactured and distributed sterile in compliance with fda, state, local laws and regulations, and acell's operating procedures.Acell's investigation is complete.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GENTRIX SURGICAL MATRIX THIN
Type of Device
GENTRIX SURGICAL MATRIX THIN
Manufacturer (Section D)
ACELL, INC.
6640 eli whitney dr.
columbia MD 21046
MDR Report Key8745294
MDR Text Key149546176
Report Number3005920706-2019-00013
Device Sequence Number1
Product Code FTM
Combination Product (y/n)N
PMA/PMN Number
K162554
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 06/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 06/01/2019
Initial Date FDA Received06/28/2019
Supplement Dates Manufacturer Received06/01/2019
Supplement Dates FDA Received07/23/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-